GlassScriptPhysician profile
Terri D Congleton
NPI 1124129465
$3,178.06
in general payments reported to CMS, 2019-2025
35 companies · $906 in 2025
The $906 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $525 · 2022: $465 · 2023: $637 · 2024: $645 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $450.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $442.45 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $424.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $310.72 | 2021-2025 | Farxiga, Airsupra |
| Amgen INC. | $253.58 | 2021-2025 | Evenity, Repatha, Prolia |
| Pfizer INC. | $235.94 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.31 | 2022-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $80.95 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.68 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $63.53 | 2021-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $57.52 | 2022-2025 | Rexulti |
| Abbott Laboratories | $51.54 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $50.30 | 2023-2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $48.88 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $47.70 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $46.45 | 2023-2025 | Trintellix |
| Exact Sciences Corporation | $45.24 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $38.14 | 2021 | |
| Sumitomo Pharma America, INC. | $37.80 | 2023-2024 | Gemtesa |
| Corcept Therapeutics | $34.38 | 2022-2024 | Korlym |
| Medtronic, INC. | $33.03 | 2024-2025 | Minimed 780g |
| Axsome Therapeutics, INC. | $31.34 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $28.13 | 2023 | Seglentis, Livalo |
| Zealand Pharma US, INC. | $27.37 | 2021 | |
| Krystal Biotech INC | $22.49 | 2024 | Vyjuvek |
| Nevro Corp. | $19.81 | 2023 | Senza |
| Inspire Medical Systems, INC. | $19.35 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $18.46 | 2025 | Aptima |
| Lundbeck LLC | $17.21 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.92 | 2021 | |
| Esperion Therapeutics, INC. | $16.65 | 2024 | Nexletol |
| Phathom Pharmaceuticals, INC. | $16.45 | 2024 | Voquezna |
| Mannkind Corporation | $15.57 | 2023 | Afrezza |
| Qiagen, LLC | $15.46 | 2022 | |
| Insulet Corporation | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Congleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.